Credit Suisse Ag Karyopharm Therapeutics Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$1.79 - $4.59 $78,856 - $202,207	-44,054 Reduced 28.87%	108,539 $194,000
Q1 2023 May 10, 2023	BUY	$2.84 - $3.92 $30,299 - $41,822	10,669 Added 7.52%	152,593 $593,000
Q4 2022 Feb 13, 2023	BUY	$2.48 - $5.93 $6,901 - $16,503	2,783 Added 2.0%	141,924 $482,000
Q3 2022 Nov 10, 2022	BUY	$4.08 - $5.82 $1,815 - $2,589	445 Added 0.32%	139,141 $760,000
Q2 2022 Aug 12, 2022	BUY	$4.15 - $8.37 $2,232 - $4,503	538 Added 0.39%	138,696 $626,000
Q1 2022 May 16, 2022	BUY	$5.91 - $14.38 $449,248 - $1.09 Million	76,015 Added 122.32%	138,158 $1.02 Million
Q4 2021 Feb 14, 2022	SELL	$5.21 - $8.61 $122,283 - $202,085	-23,471 Reduced 27.41%	62,143 $398,000
Q3 2021 Nov 12, 2021	BUY	$4.45 - $10.63 $7,342 - $17,539	1,650 Added 1.97%	85,614 $498,000
Q2 2021 Aug 16, 2021	SELL	$8.11 - $11.11 $47,857 - $65,560	-5,901 Reduced 6.57%	83,964 $866,000
Q1 2021 May 14, 2021	SELL	$9.85 - $17.69 $1.22 Million - $2.19 Million	-124,068 Reduced 57.99%	89,865 $945,000
Q4 2020 Feb 12, 2021	SELL	$14.15 - $17.19 $176,903 - $214,909	-12,502 Reduced 5.52%	213,933 $3.31 Million
Q3 2020 Nov 13, 2020	SELL	$14.14 - $19.71 $110,292 - $153,738	-7,800 Reduced 3.33%	226,435 $3.31 Million
Q2 2020 Aug 12, 2020	BUY	$16.6 - $25.25 $2.39 Million - $3.64 Million	144,037 Added 159.69%	234,235 $4.44 Million
Q1 2020 May 13, 2020	SELL	$14.38 - $27.72 $340,273 - $655,938	-23,663 Reduced 20.78%	90,198 $1.73 Million
Q4 2019 Feb 12, 2020	BUY	$9.23 - $19.67 $663,637 - $1.41 Million	71,900 Added 171.35%	113,861 $2.18 Million
Q3 2019 Nov 12, 2019	SELL	$5.66 - $11.85 $303,879 - $636,214	-53,689 Reduced 56.13%	41,961 $403,000
Q2 2019 Aug 14, 2019	SELL	$4.32 - $6.43 $33,147 - $49,337	-7,673 Reduced 7.43%	95,650 $572,000
Q1 2019 May 14, 2019	BUY	$4.12 - $10.25 $153,746 - $382,499	37,317 Added 56.54%	103,323 $603,000
Q4 2018 Feb 13, 2019	BUY	$8.2 - $16.95 $163,524 - $338,016	19,942 Added 43.29%	66,006 $618,000
Q3 2018 Nov 13, 2018	SELL	$17.03 - $21.18 $13,164 - $16,372	-773 Reduced 1.65%	46,064 $784,000
Q2 2018 Aug 14, 2018	BUY	$12.0 - $19.88 $8,976 - $14,870	748 Added 1.62%	46,837 $796,000
Q1 2018 May 15, 2018	BUY	$9.92 - $17.25 $59,877 - $104,121	6,036 Added 15.07%	46,089 $619,000
Q4 2017 Feb 14, 2018	BUY	$9.15 - $11.99 $73,328 - $96,087	8,014 Added 25.01%	40,053 $384,000
Q3 2017 Nov 14, 2017	BUY	$8.15 - $11.16 $173,595 - $237,708	21,300 Added 198.34%	32,039 $352,000
Q2 2017 Aug 14, 2017	BUY	N/A	10,739	10,739 $97,000

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

Vanguard Group Inc Valley Forge, PA

7.65M
Shares

$5.05 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

5.55M
Shares

$3.66 Million
0.36% of portfolio
Palo Alto Investors LP Palo Alto, CA

5.1M
Shares

$3.37 Million
0.58% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

4.32M
Shares

$2.85 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.17M
Shares

$2.75 Million
0.0% of portfolio

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $52.7M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account